1. Home
  2. CYCC vs BYFC Comparison

CYCC vs BYFC Comparison

Compare CYCC & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • BYFC
  • Stock Information
  • Founded
  • CYCC 1992
  • BYFC 1946
  • Country
  • CYCC Malaysia
  • BYFC United States
  • Employees
  • CYCC N/A
  • BYFC N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • BYFC Savings Institutions
  • Sector
  • CYCC Health Care
  • BYFC Finance
  • Exchange
  • CYCC Nasdaq
  • BYFC Nasdaq
  • Market Cap
  • CYCC 61.2M
  • BYFC 63.8M
  • IPO Year
  • CYCC N/A
  • BYFC 1996
  • Fundamental
  • Price
  • CYCC $0.32
  • BYFC $7.28
  • Analyst Decision
  • CYCC
  • BYFC
  • Analyst Count
  • CYCC 0
  • BYFC 0
  • Target Price
  • CYCC N/A
  • BYFC N/A
  • AVG Volume (30 Days)
  • CYCC 3.9M
  • BYFC 7.4K
  • Earning Date
  • CYCC 08-13-2025
  • BYFC 07-29-2025
  • Dividend Yield
  • CYCC N/A
  • BYFC N/A
  • EPS Growth
  • CYCC N/A
  • BYFC N/A
  • EPS
  • CYCC N/A
  • BYFC N/A
  • Revenue
  • CYCC $14,000.00
  • BYFC $32,732,999.00
  • Revenue This Year
  • CYCC $137.21
  • BYFC N/A
  • Revenue Next Year
  • CYCC N/A
  • BYFC N/A
  • P/E Ratio
  • CYCC N/A
  • BYFC N/A
  • Revenue Growth
  • CYCC N/A
  • BYFC N/A
  • 52 Week Low
  • CYCC $0.25
  • BYFC $4.68
  • 52 Week High
  • CYCC $39.84
  • BYFC $9.46
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 25.85
  • BYFC 69.81
  • Support Level
  • CYCC $0.31
  • BYFC $5.92
  • Resistance Level
  • CYCC $0.41
  • BYFC $6.68
  • Average True Range (ATR)
  • CYCC 0.07
  • BYFC 0.25
  • MACD
  • CYCC 0.10
  • BYFC 0.10
  • Stochastic Oscillator
  • CYCC 38.57
  • BYFC 68.12

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: